Editas Medicine (STU:8EM) Cyclically Adjusted Book per Share: €4.89 (As of Mar. 2026)


STU:8EM Editas Medicine Inc STU:8EM
40 GF Score
Price €3.29
GF Value €1.62
Valuation Significantly Overvalued
! 11 Warning Signs
View Full Analysis

What is Editas Medicine Cyclically Adjusted Book per Share?

Editas Medicine STU:8EM +3.46% 40 Cyclically Adjusted Book per Share is €4.89 as of Mar. 2026. GuruFocus rates STU:8EM with a GF Score™ of 40/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 11 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Editas Medicine's adjusted book value per share for the three months ended in Mar. 2026 was €0.039. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Editas Medicine's average Cyclically Adjusted Book Growth Rate was -3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-08), Editas Medicine's current stock price is €3.29. Editas Medicine's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €4.89. Editas Medicine's Cyclically Adjusted PB Ratio of today is 0.67.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Editas Medicine was 0.98. The lowest was 0.18. And the median was 0.44.


Editas Medicine  (STU:8EM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Editas Medicine's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.29/4.89
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Editas Medicine was 0.98. The lowest was 0.18. And the median was 0.44.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Editas Medicine Cyclically Adjusted Book per Share Related Terms


Editas Medicine Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Editas Medicine's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Editas Medicine Cyclically Adjusted Book per Share Chart

Editas Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 5.29 4.81

Editas Medicine Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.40 5.04 4.75 4.81 4.89

STU:8EM vs SGMT, AUTL, FBRX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Editas Medicine's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Editas Medicine Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Editas Medicine's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Editas Medicine's Cyclically Adjusted PB Ratio falls into.


STU:8EM
40GF Score
Editas Medicine Inc STU:8EM
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Editas Medicine Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Editas Medicine's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.039/330.2130*330.2130
=0.039

Current CPI (Mar. 2026) = 330.2130.

Editas Medicine Quarterly Data

Book Value per Share CPI Adj_Book
201606 4.713 241.018 6.457
201609 4.258 241.428 5.824
201612 3.563 241.432 4.873
201703 4.742 243.801 6.423
201706 4.024 244.955 5.425
201709 3.565 246.819 4.770
201712 3.950 246.524 5.291
201803 4.297 249.554 5.686
201806 4.182 251.989 5.480
201809 4.049 252.439 5.296
201812 4.257 251.233 5.595
201903 3.928 254.202 5.103
201906 3.470 256.143 4.473
201909 3.733 256.759 4.801
201912 4.345 256.974 5.583
202003 3.874 258.115 4.956
202006 6.102 257.797 7.816
202009 6.023 260.280 7.641
202012 5.171 260.474 6.555
202103 7.943 264.877 9.902
202106 7.469 271.696 9.078
202109 7.300 274.310 8.788
202112 7.160 278.802 8.480
202203 6.787 287.504 7.795
202206 6.407 296.311 7.140
202209 6.092 296.808 6.778
202212 4.945 296.797 5.502
202303 4.298 301.836 4.702
202306 4.523 305.109 4.895
202309 4.136 307.789 4.437
202312 3.915 306.746 4.215
202403 3.294 312.332 3.483
202406 2.615 314.175 2.748
202409 1.917 315.301 2.008
202412 1.550 315.605 1.622
202503 0.690 319.799 0.712
202506 0.190 322.561 0.195
202509 0.123 324.800 0.125
202512 0.238 324.054 0.243
202603 0.039 330.213 0.039

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €4.89 mean?
Editas Medicine (STU:8EM) has a Cyclically Adjusted Book per Share of €4.89 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Editas Medicine and its competitors.
Is Editas Medicine's Cyclically Adjusted Book per Share too high?
Editas Medicine's current Cyclically Adjusted Book per Share is €4.89. Overall, Editas Medicine has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Editas Medicine's Cyclically Adjusted Book per Share compare to SGMT and AUTL?
Editas Medicine's Cyclically Adjusted Book per Share of €4.89 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Editas Medicine and its competitors. Editas Medicine's current Cyclically Adjusted Book per Share is €4.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Editas Medicine stock overvalued right now?
Based on GuruFocus' analysis, Editas Medicine (STU:8EM) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €3.29 — trading 103.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is €4.89. Editas Medicine's overall GF Score™ is 40/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Editas Medicine (STU:8EM), the current Cyclically Adjusted Book per Share is €4.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Editas Medicine (STU:8EM) Overvalued in 2026?

Based on GuruFocus' analysis, Editas Medicine stock appears to be overvalued. The current stock price of €3.29 is trading 103.1% above its estimated GF Value™ of €1.62. GuruFocus considers Editas Medicine to be Significantly Overvalued.

Key valuation signals for STU:8EM:

  • Cyclically Adjusted Book per Share: €4.89
  • GF Value™: €1.62 vs. price of €3.29 (103.1% above fair value)
  • GF Score™: 40/100 with 11 warning signs

No single metric tells the full story. See the STU:8EM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Editas Medicine Business Description

Other Exchanges EDIT:USA0IFK:UK
Address 11 Hurley Street, Cambridge, MA, USA, 02141
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
40GF Score

Get the complete analysis for STU:8EM

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.29
Price
€1.62
GF Value